Cargando…
Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma
Mantle cell lymphoma (MCL) is an aggressive haematological malignancy in which the response to therapy can be limited by aberrantly activated molecular and cellular pathways, among which autophagy was recently listed. Our study shows that the 9-cis-retinoic acid (RA)/Interferon(IFN)-α combination in...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173105/ https://www.ncbi.nlm.nih.gov/pubmed/27248824 http://dx.doi.org/10.18632/oncotarget.9630 |
_version_ | 1782484264109998080 |
---|---|
author | Mastorci, Katy Montico, Barbara Faè, Damiana A. Sigalotti, Luca Ponzoni, Maurilio Inghirami, Giorgio Dolcetti, Riccardo Col, Jessica Dal |
author_facet | Mastorci, Katy Montico, Barbara Faè, Damiana A. Sigalotti, Luca Ponzoni, Maurilio Inghirami, Giorgio Dolcetti, Riccardo Col, Jessica Dal |
author_sort | Mastorci, Katy |
collection | PubMed |
description | Mantle cell lymphoma (MCL) is an aggressive haematological malignancy in which the response to therapy can be limited by aberrantly activated molecular and cellular pathways, among which autophagy was recently listed. Our study shows that the 9-cis-retinoic acid (RA)/Interferon(IFN)-α combination induces protective autophagy in MCL cell lines and primary cultures reducing the extent of drug-induced apoptosis. The treatment significantly up-regulates phospholipid scramblase 1 (PLSCR1), a protein which bi-directionally flips lipids across membranes. In particular, RA/IFN-α combination concomitantly increases PLSCR1 transcription and controls PLSCR1 protein levels via lysosomal degradation. Herein we describe a new function for PLSCR1 as negative regulator of autophagy. Indeed, PLSCR1 overexpression reduced MCL cell susceptibility to autophagy induced by RA/IFN-α, serum deprivation or mTOR pharmacological inhibition. Moreover, PLSCR1 can bind the ATG12/ATG5 complex preventing ATG16L1 recruitment and its full activation, as indicated by co-immunoprecipitation experiments. The combination of doxorubicin or bortezomib with RA/IFN-α strengthened PLSCR1 up-regulation and enhanced apoptosis, as a likely consequence of the blockade of RA/IFN-α-induced autophagy. Immunohistochemical analysis of 32 MCL biopsies revealed heterogeneous expression of PLSCR1 and suggests its possible implication in the response to anticancer therapies, especially to drugs promoting protective autophagy. |
format | Online Article Text |
id | pubmed-5173105 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-51731052016-12-23 Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma Mastorci, Katy Montico, Barbara Faè, Damiana A. Sigalotti, Luca Ponzoni, Maurilio Inghirami, Giorgio Dolcetti, Riccardo Col, Jessica Dal Oncotarget Research Paper Mantle cell lymphoma (MCL) is an aggressive haematological malignancy in which the response to therapy can be limited by aberrantly activated molecular and cellular pathways, among which autophagy was recently listed. Our study shows that the 9-cis-retinoic acid (RA)/Interferon(IFN)-α combination induces protective autophagy in MCL cell lines and primary cultures reducing the extent of drug-induced apoptosis. The treatment significantly up-regulates phospholipid scramblase 1 (PLSCR1), a protein which bi-directionally flips lipids across membranes. In particular, RA/IFN-α combination concomitantly increases PLSCR1 transcription and controls PLSCR1 protein levels via lysosomal degradation. Herein we describe a new function for PLSCR1 as negative regulator of autophagy. Indeed, PLSCR1 overexpression reduced MCL cell susceptibility to autophagy induced by RA/IFN-α, serum deprivation or mTOR pharmacological inhibition. Moreover, PLSCR1 can bind the ATG12/ATG5 complex preventing ATG16L1 recruitment and its full activation, as indicated by co-immunoprecipitation experiments. The combination of doxorubicin or bortezomib with RA/IFN-α strengthened PLSCR1 up-regulation and enhanced apoptosis, as a likely consequence of the blockade of RA/IFN-α-induced autophagy. Immunohistochemical analysis of 32 MCL biopsies revealed heterogeneous expression of PLSCR1 and suggests its possible implication in the response to anticancer therapies, especially to drugs promoting protective autophagy. Impact Journals LLC 2016-05-26 /pmc/articles/PMC5173105/ /pubmed/27248824 http://dx.doi.org/10.18632/oncotarget.9630 Text en Copyright: © 2016 Mastorci et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Mastorci, Katy Montico, Barbara Faè, Damiana A. Sigalotti, Luca Ponzoni, Maurilio Inghirami, Giorgio Dolcetti, Riccardo Col, Jessica Dal Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma |
title | Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma |
title_full | Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma |
title_fullStr | Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma |
title_full_unstemmed | Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma |
title_short | Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma |
title_sort | phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173105/ https://www.ncbi.nlm.nih.gov/pubmed/27248824 http://dx.doi.org/10.18632/oncotarget.9630 |
work_keys_str_mv | AT mastorcikaty phospholipidscramblase1asacriticalnodeatthecrossroadbetweenautophagyandapoptosisinmantlecelllymphoma AT monticobarbara phospholipidscramblase1asacriticalnodeatthecrossroadbetweenautophagyandapoptosisinmantlecelllymphoma AT faedamianaa phospholipidscramblase1asacriticalnodeatthecrossroadbetweenautophagyandapoptosisinmantlecelllymphoma AT sigalottiluca phospholipidscramblase1asacriticalnodeatthecrossroadbetweenautophagyandapoptosisinmantlecelllymphoma AT ponzonimaurilio phospholipidscramblase1asacriticalnodeatthecrossroadbetweenautophagyandapoptosisinmantlecelllymphoma AT inghiramigiorgio phospholipidscramblase1asacriticalnodeatthecrossroadbetweenautophagyandapoptosisinmantlecelllymphoma AT dolcettiriccardo phospholipidscramblase1asacriticalnodeatthecrossroadbetweenautophagyandapoptosisinmantlecelllymphoma AT coljessicadal phospholipidscramblase1asacriticalnodeatthecrossroadbetweenautophagyandapoptosisinmantlecelllymphoma |